Dear HKNOS members,
HKNOS AGM & ASM, 7 November 2025 (Friday)
We are pleased to invite you all to the HKNOS Annual General Meeting (AGM), which will be held before the Annual Scientific Meeting (ASM) on 7th Nov 2025 (Fri), with details as follows:
Date: 7 November, 2025 (Friday)
Time: 18:00-19:00 (AGM), 19:00-22:00 (ASM)
Venue: Shanghai Room I, Level 8, Cordis Hotel, Mongkok, Kowloon
Topic: Latest Advances on Treatment of Recurrent Brain Tumors
Kindly register here for the event.
Looking forward to seeing you all.
Best regards,
John FONG
Sent on behalf of Dr. Jason HO (Honorary Secretary)
The Hong Kong Neuro-Oncology Society
Sponsors:

Our founder’s wisdom – “Medicine is for the people”, we uphold a human-centric perspective to serve our Hong Kong society. Today, we are one of the top five biopharmaceutical companies in Hong Kong, specialising on prevention work and treatment of different diseases including COVID-19, oncology, and cardiovascular.
![]()
https://www.novartis.com/hk-zh/
Rooted in Hong Kong for over 75 years, Novartis benefits more than one million local patients annually with over 100 registered innovative medicines. We focus on innovative medicines, leveraging advanced technology platforms to provide treatments in five core areas: cardiovascular, immunology, solid tumors, hematology, and neuroscience.
![]()
https://www.actgenomics.com/zh-hk
ACT Genomics is an award-winning cancer solution provider founded in 2014 by a small group of scientists from academia. With our name, ACT Genomics, reflecting our passion to “turn genomics into action”, we set out to apply academic theories in clinical practice and truly make personalized cancer care accessible to all.
![]()
https://www.zailaboratory.com/
